Calvert Formula, Mawer (f)

GFR Mawer

Loading...

GFR Mawer

mg/ml*min
yrs

References

  1. Jennifer S Lees. Accuracy of glomerular filtration rate estimates among patients with cancer.. British journal of cancer, 2025
  2. Geeta Sandhu. Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice.. EClinicalMedicine, 2025
  3. Natalie Ebert. Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium.. Kidney international, 2024
  4. NA. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.. Kidney international, 2024
  5. A. Horiike. Adjustment of creatinine (Cr) to avoid severe thrombocytopenia of carboplatin (C) plus gemcitabine (G) in non-small cell lung cancer (NSCLC).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016
  6. R. Cathomas. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.. Annals of oncology : official journal of the European Society for Medical Oncology, 2014
  7. T. Oguri. 1545PCARBOPLATIN DOSING WITH THE CALVERT FORMULA FOR ADULT JAPANESE PATIENTS WITH RENAL INSUFFICIENCY.. Annals of oncology : official journal of the European Society for Medical Oncology, 2014
  8. M. Okera. The effect of Cockcroft-Gault (CG) measurement of GFR on carboplatin dosage in ovarian cancer patients compared with Cr51-EDTA.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011
  9. T. Shimokata. Evaluation of renal function and carboplatin clearance in Japanese cancer patients.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009
  10. A H Calvert. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989